LaCE (Lactobacillus Paracasei LPB27 On Early Childhood Eczema) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

LaCE (Lactobacillus Paracasei LPB27 On Early Childhood Eczema) — Stella

Recruiting

Back to Eczema trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Australia

Sydney Children's Hospital, Randwick, New South Wales

Key details

Phase

Safety & dosing

Sponsor

The University of New South Wales

Collaborators

Evolution Health Pty Ltd

Enrollment target

~100 participants

Started

November 2024

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

3 Months – 3 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov